Swiss agree to extradite Chinese researcher in US corporate espionage case
The case has exacerbated global fears that China is using networks of highly trained nationals abroad to gain trade secrets,
swissinfo.ch
This content was published on
2 minutes
The Swiss Federal Office of Justice (FOJ)External link has approved the extradition of a Chinese researcher to the United States. Gongda Xue is charged with using trade secrets stolen from a factory of the British pharmaceutical group GlaxoSmithKline (GSK).
The decision was taken on July 12, from which date the researcher has 30 days to appeal to the Federal Criminal Court, a spokeswoman for the FOJ told the French news agency, AFP, on Tuesday.
Gongda Xue is the brother of Yu Xue, a Chinese-American biochemist who pleaded guilty last year at a US District Court in Pennsylvania to stealing trade secrets on GSK’s work in the biopharmaceutical sector, including the treatment of cancer and other serious diseases.
A total of five people were charged in the case, three of whom formed a company in China called Renopharma to sell the stolen trade secrets.
Yu Xue, who worked for GSK from 2006 to 2016, had been presented by the American courts as one of the “leading protein biochemists in the world”.
According to a spokeswoman for the Friedrich Miescher Institute for Biomedical Research, Gongda Xue worked there “as a postdoctoral fellow from 2008 to 2014”.
The US Department of Justice last year called the case an “economic war”, claiming that Renopharma, based in Nanjing, China, is “financed by the Chinese government”.
Popular Stories
More
Swiss Abroad
Heimatort, sweet Heimatort: the unique Swiss concept of home
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
Myanmar earthquake: foreign ministry has no news on Swiss victims
This content was published on
The Swiss foreign ministry is not yet aware of any Swiss nationals among the victims or those affected by the earthquake that struck central Myanmar.
Swiss military jet crash: air traffic controller found guilty
This content was published on
Over eight and a half years after the fatal F/A-18 military jet accident in Switzerland, an air traffic controller has been found guilty of negligent homicide by a military appeals court.
Viola Amherd hands over keys of Swiss defence ministry to Martin Pfister
This content was published on
On Friday, the new Swiss government minister Martin Pfister was symbolically presented with the keys to the Federal Department of Defence, Civil Protection and Sport by outgoing minister Viola Amherd.
PostFinance cancels accounts of customers with Cuba links
This content was published on
The financial services arm of the Swiss post office, PostFinance, has cancelled the accounts of several customers with links to Cuba as a consequence of US sanctions against the Caribbean island state.
Basel cannabis study reports improvements in smokers’ mental health
This content was published on
After two years, a legal recreational cannabis study known as "Weedcare", carried out in Basel in northwestern Switzerland, has been given a positive assessment.
Group reports rise in anti-Semitic incidents in French-speaking Switzerland
This content was published on
Anti-Semitic incidents rose by almost 90% in French-speaking Switzerland last year, according to the Intercommunity Coordination Against Anti-Semitism and Defamation (known by its French name CICAD).
Number of Swiss around the world grew by 1.6% in 2024
This content was published on
Last year, 13,300 Swiss citizens moved abroad, taking the total number of Swiss Abroad to 826,700 (+1.6%). Three-quarters have more than one nationality, new figures show.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss firms in record number of mergers and acquisitions
This content was published on
The number of merger and acquisition deals involving Swiss companies hit a record high in 2018, according to a report by consultancy firm KPMG.
This content was published on
In recent days, Johnson & Johnson has been urged to review its sprawling portfolio that ranges from baby oil to cancer drugs, and there were questions for Novartis over the future of its struggling eyecare business. This week, Pfizer will update shareholders on plans for a potential break-up, while GlaxoSmithKline is likely to be pressed…
Chinese researcher in ‘economic warfare’ case loses appeal
This content was published on
A Chinese scientist, accused by the US of helping to steal trade secrets, must remain in Swiss custody due to flight risk, says a federal court.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.